TI
SRNE

Trexquant Investment’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Trexquant Investment’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-67,929
Closed -$592K – 1240
2015
Q4 		$592K Buy
67,929
+44,129
+185% +$372K 0.05% 615
2015
Q3 		$199K Sell
23,800
-4,500
-16% -$71.7K 0.02% 973
2015
Q2 		$498K Buy
+28,300
New +$364K 0.06% 624

Other funds holding SRNE

WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Trexquant Investment's SRNE Position: Q1 2016 in Review

Trexquant Investment sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2016, closing a stake of 67,929 shares — an estimated $592K sold.

Trexquant Investment first reported a position in SRNE in Q2 2015 and held it in 3 quarters. The position peaked at $592K in Q4 2015. 68 funds tracked by Wall St. Rank hold SRNE as of Q1 2016.

  • Trexquant Investment reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2016 after selling out during the quarter.
  • Trexquant Investment sold 67,929 Sorrento Therapeutics, Inc. shares in Q1 2016, an estimated $592K.
  • Trexquant Investment first reported a position in Sorrento Therapeutics, Inc. in Q2 2015 and held it in 3 quarters.
  • Trexquant Investment's Sorrento Therapeutics, Inc. position peaked at $592K in Q4 2015.
  • 68 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2016.

Based on Trexquant Investment's 13F filing for Q1 2016, filed 11 May 2016.